Press Releases
HOUSTON, May 2, 2024 /PRNewswire/ -- Summit Midstream Partners, LP (NYSE: SMLP) ("Summit", "SMLP" or the "Partnership") announced today its financial and operating results for the three months ended March 31, 2024.
Highlights
- Reduced net leverage ratio to approximately 3.9x, a dramatic reduction from 5.4x in the fourth quarter of 2023, furthering... (continue reading...)
Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for IBSRELA and $15.2 million in net product sales revenue for XPHOZAH
Company ends Q1 with approximately $203 million in cash and investments
Conference call scheduled for 4:30 PM Eastern Time
WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and... (continue reading...)
HUNTINGTON BEACH, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ: BJRI) today reported financial results for its fiscal 2024 first quarter ended Tuesday, April 2, 2024.
Fiscal First Quarter 2024 Compared to First Quarter 2023
- Total revenues decreased 1.2% to $337.3 million
- Comparable restaurant sales declined 1.7%
- Total restaurant operating weeks increased by one week
- Net income of $7.7 million, compared to $3.5 million; diluted... (continue reading...)
BURLINGAME, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on May 6, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update and report first quarter 2024 financial results.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) or by clicking on ... (continue reading...)
New York, New York--(Newsfile Corp. - May 2, 2024) - BlockchainK2 Corp. (TSXV: BITK) (OTCQB: BIDCF) (FSE: KRL2) ("BlockchainK2" or the "Company") is pleased to announce appointment of Scott Brooks as CEO of RealBlocks (Enverxergy Inc. dba "RealBlocks" www.Realblocks.com) and as a director of the Company. Mr. Brooks is a seasoned financial services leader with over 35 years of experience in asset management and financial services. Most recently, he consulted with... (continue reading...)
More Press Releases
View Older Stories-
Pro-Dex, Inc. Announces Fiscal 2024 Third Quarter And Nine-Month Results
-
CSX Executive Vice President and Chief Commercial Officer to Address Bank of America Transportation, Airlines and Industrials Conference
-
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
-
Vermilion Energy Inc. Reports Voting Results of Annual General Meeting
-
Mustang Bio Announces Closing of $4 Million Public Offering
-
AAON REPORTS FIRST QUARTER OF 2024 RESULTS
-
Aritzia Reports Fourth Quarter and Fiscal 2024 Financial Results
-
2U Reports Results for First Quarter 2024
-
STANDEX REPORTS FISCAL THIRD QUARTER 2024 FINANCIAL RESULTS
-
AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
-
Clear Cut Hero and X3 Performance & Physical Therapy Announce Record NFL Draft Results
-
Expedia Group Reports First Quarter 2024 Results
-
OpenText Reports Q3 F'24 Financial Results
-
Hologic Announces Financial Results for Second Quarter of Fiscal 2024
-
Asure Announces First Quarter 2024 Results
-
OneSpan Reports First Quarter 2024 Financial Results
-
Bimini Capital Management Announces First Quarter 2024 Results
-
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
-
EMCORE Announces Sale of Chips Business and Wafer Fabrication Operations for $2.92M and Certain Assumed Liabilities
-
Upland Software Reports First Quarter 2024 Financial Results
-
Ascendis Pharma Reports First Quarter 2024 Financial Results
-
Kopin to Demonstrate Day and Night Readable Warfighter Vision Concepts at SOF Week
-
4M Therapeutics Announces Formation of Clinical Advisory Board with Experts in Neuropsychiatry and Neurodegeneration
-
Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma
-
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
-
NetApp Hosts Fourth Quarter and Fiscal Year 2024 Financial Results Webcast
-
Silvercrest Asset Management Group Inc. Reports Q1 2024 Results
-
Willscot Mobile Mini Reports First Quarter 2024 Results
-
Alignment Healthcare Reports First Quarter 2024 Results
-
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
-
WW International, Inc. Announces First Quarter 2024 Results
-
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
-
Aspen Group, Inc. Amends Debentures
-
Nerdy to Participate in Needham Conference
-
Gevo Reports First Quarter 2024 Financial Results
-
Galapagos reports first quarter 2024 financial results
-
Badger Announces Voting Results of 2024 Annual Meeting of Shareholders
-
Precision Drilling Corporation Holding Virtual-Only 2024 Annual and Special Meeting of Shareholders on May 16
-
Clearfield Reports Second Quarter 2024 Results
-
MLS Technology Holdings, LLC Announces Joe Kazzoun as CEO of Remine
-
NuZee, Inc. Announces Completion of Private Placement of Convertible Note and Warrants
-
Beacon Reports First Quarter 2024 Results
-
Experience Premier Skincare Solutions at Capri Med Spa in Glendale, California
-
Cerus Corporation Announces First Quarter 2024 Financial Results
-
Qualtrics Announces 2024 XM Breakthrough Artist Award Winners
-
Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing
-
Maiden Holdings, Ltd. to Release First Quarter 2024 Earnings on May 9, 2024
-
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update